TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Dow Futures Flat, Global Stocks Retreat Amid Fading U.S.-China Trade Hopes
STOCKS

Stocks Hold Gains on US-China Trade Optimism, Strong Start to Q4 Earnings Season

PRESS RELEASES

IIROC Trading Resumption - SLS

PRESS RELEASES

IIROC Trading Halt - SLS

PRESS RELEASES

SELLAS Announces Pricing Of $16.2 Million Registered Direct Offering

PRESS RELEASES

SELLAS Announces Positive Follow-up Data From The Randomized Phase 2 VADIS Trial Of Nelipepimut-S (NPS) In Women With Ductal Carcinoma In-Situ Of The Breast

PRESS RELEASES

SELLAS Life Sciences And 3D Medicines Announce Exclusive License Agreement For Development And Commercialization Of Galinpepimut-S (GPS) And GPS In Greater China

PRESS RELEASES

IIROC Trading Halt - SLS

PRESS RELEASES

SELLAS Life Sciences Provides Business Update And Reports Third Quarter 2020 Financial Results

PRESS RELEASES

IIROC Trading Resumption - SLS

PRESS RELEASES

IIROC Trading Halt - SLS

PRESS RELEASES

Solaris Announces New U.S. Listing On OTCQB Venture Market Under Symbol "SLSSF"

PRESS RELEASES

SELLAS Receives IMPD Approval From The French Regulatory Authority For Its Pivotal Phase 3 REGAL Study Of Galinpepimut-S In Patients With Acute Myeloid Leukemia

PRESS RELEASES

SELLAS Life Sciences Provides Business Update And Reports Second Quarter 2020 Financial Results

PRESS RELEASES

IIROC Trading Resumption - SLS

PRESS RELEASES

IIROC Trading Halt - SLS

PRESS RELEASES

SELLAS Life Sciences Announces $9.2 Million Private Placement Priced At-The-Market

PRESS RELEASES

C-Suite At The Open: Daniel Earle, President & CEO, Solaris Resources Inc. Tells His Company's Story. Filmed In June, 2020

PRESS RELEASES

Solaris Resources Inc. Virtually Opens The Market

PRESS RELEASES

SELLAS To Host Virtual Annual Meeting Of Stockholders

PRESS RELEASES

SELLAS Establishes Independent Data Monitoring Committee Of Leading Clinical And Biostatistics Experts For Pivotal Phase 3 REGAL Clinical Trial

PRESS RELEASES

SELLAS Life Sciences Reports First Quarter 2020 Financial Results And Provides Business Update

PRESS RELEASES

SELLAS To Present At UBS Virtual Global Healthcare Conference

PRESS RELEASES

SELLAS Releases Annual Letter To Shareholders

PRESS RELEASES

SELLAS Appoints Steering Committee Of Leading Acute Myeloid Leukemia Experts For Its Ongoing Phase 3 REGAL Clinical Trial In AML

PRESS RELEASES

SELLAS Life Sciences Reports Full Year 2019 Financial Results And Provides Business Update